Epidemiological studies suggest that aspirin and other nonsteroidal anti-inflammatory drugs
(NSAIDs) reduce the incidence of and mortality from colorectal, gastric, and esophageal …

In recent years, several areas of biological research have increasingly supported the
suggestion that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) may …

Regular intake of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) is
associated with a decreased incidence of colorectal, esophageal, gastric, and lung cancer …

Several epidemiological, clinical and experimental studies established nonsteroidal anti-
inflammatory drugs (NSAIDs) as promising cancer chemopreventive agents. Long-term use …

Use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) has been
associated with reduced risk of colorectal cancer. Moreover, the NSAID sulindac reduces the …

The cyclooxygenase (COX) enzymes (COX-1 and COX-2) are key enzymes of prostaglandin
(PG) biosynthesis. Nonselective non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the …

▪ Abstract Nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, appear to have
clinically significant anticarcinogenic effects in the gastrointestinal tract. Epidemiological …

OBJECTIVE: To discuss the role of nonsteroidal antiinflammatory drugs (NSAIDs) in the
chemoprevention of colorectal cancer. DATA SOURCES: A MEDLINE search (1966–May …

Large bowel cancer is not only the third most frequent cancer in the world but is one of the
most common human malignancies in Western countries, including North America. In recent …

Increasing evidence suggests that aspirin and other nonsteroidal anti-inflammatory drugs
(NSAIDs) reduce the risk of colorectal cancer. This observation is supported by results from …